BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Perrigo Company 

515 Eastern Avenue

Allegan  Michigan  49010  U.S.A.
Phone: 616-673-8451 Fax: 616-673-9128


SEARCH JOBS




Industry
Pharmaceutical






 Company News
Perrigo Company (PRGO) Announces Exchange Offer For Its 1.30% Senior Notes Due 2016, 2.30% Senior Notes Due 2018, 4.00% Senior Notes Due 2023 and 5.30% Senior Notes Due 2043 9/4/2014 1:26:36 PM
Bayer AG (BAYZF), Boehringer Ingelheim Corporation, Perrigo Company (PRGO), And Sanofi (France) (SAN.PA) Linked To Omega Pharma NV (0OMEP.BR) Sale; Deal Could Cost More Than $5.3 Billion 8/29/2014 5:55:41 AM
Perrigo Company (PRGO) Reports Record Fourth Quarter And Fiscal Year Revenue, Adjusted Operating Income And Adjusted Margins 8/14/2014 9:05:53 AM
Perrigo Company (PRGO) Announces Quarterly Dividend 8/14/2014 8:00:57 AM
Perrigo Company (PRGO) To Release Fourth Quarter And Fiscal Year 2014 Results On August 14, 2014 7/31/2014 9:56:15 AM
Perrigo Company (PRGO) Confirms First To File Patent Challenge For Generic Version Of Topicort® Topical Spray 0.25% 7/30/2014 8:29:27 AM
Perrigo Company (PRGO) Confirms AB Therapeutic Equivalent Rating From The FDA For Its Testosterone Gel 1.0% 7/28/2014 7:46:41 AM
Perrigo Company (PRGO) Announces FDA Final Approval For The Store Brand Equivalent To Advil® Congestion Relief Tablets, 200 mg/10 mg 7/8/2014 9:53:42 AM
Perrigo Company (PRGO) Announces Settlement In Proair® HFA Patent Case 6/20/2014 8:24:55 AM
Perrigo Company (PRGO) To Present At Jefferies and Co. 2014 Global Healthcare Conference 5/30/2014 7:01:37 AM
12345678910...